Llewellyn Mills, PhD
Affiliations: | 2013-2016 | School of Psychology | University of Sydney, Camperdown, New South Wales, Australia |
Google:
"Llewellyn Mills"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Mills L, Lee JC, Boakes R, et al. (2023) Reduction in caffeine withdrawal after open-label decaffeinated coffee. Journal of Psychopharmacology (Oxford, England). 2698811221147152 |
| Lintzeris N, Mills L, Dunlop A, et al. (2020) Cannabis use in patients 3 months after ceasing nabiximols for the treatment of cannabis dependence: Results from a placebo-controlled randomised trial. Drug and Alcohol Dependence. 215: 108220 |
| Deacon RM, Mammen K, Holmes J, et al. (2020) Assessing the validity of the Australian Treatment Outcomes Profile for telephone administration in drug health treatment populations. Drug and Alcohol Review |
| Mills L, Lintzeris N, Bruno R, et al. (2020) Validation of the Australian Treatment Outcomes Profile for use in clients with cannabis dependence. Drug and Alcohol Review. 39: 356-364 |
| Lintzeris N, Bhardwaj A, Mills L, et al. (2019) Nabiximols for the Treatment of Cannabis Dependence: A Randomized Clinical Trial. Jama Internal Medicine |
| Mills L, Boakes RA, Colagiuri B. (2018) The effect of dose expectancies on caffeine withdrawal symptoms during tapered dose reduction. Journal of Psychopharmacology (Oxford, England). 269881118817158 |
| Mills L, Dar-Nimrod I, Colagiuri B. (2017) Effect of Genetic Information and Information About Caffeine Content on Caffeine Withdrawal Symptoms. Scientific Reports. 7: 8407 |
| Mills L, Boakes RA, Colagiuri B. (2016) Placebo caffeine reduces withdrawal in abstinent coffee drinkers. Journal of Psychopharmacology (Oxford, England) |